Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs.

H. Res. 161 · 113th Congress · Apr 15, 2013 · Lineage

RESOLUTION

That it is the sense of the House of Representatives that the Food and Drug Administration should exercise its acknowledged authority to—

(1)

refuse to approve generic versions of non-abuse-deterrent opioid products that have been replaced in the market with abuse-deterrent formulations; and

(2)

require generic versions of abuse-deterrent opioid products to be formulated with comparable abuse-deterrent features.

Lineage

Apr 15, 2013viewing Introduced in House Mr. Rogers of Kentucky (for himself, Mr. Keating, Mr. Wolf, Mr. Rahall, Mr. Grimm, Mr. Lynch, Mr. Tierney, and Mr. Aderholt) submitted the following resolution; which was referred to the Committee on Energy and Commerce

Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs.

Cite this provision

Incoming references